Refine by
Oral Mucosal Suppliers & Manufacturers
15 companies found
Premium
based inEaston, PENNSYLVANIA (USA)
Vobis, LLC. About 20 years ago, after working for over a dozen years for several dedicated manufacturers of evaporation, crystallization, and drying technologies. Vobis designs and manufactures systems that meet your unique requirements and budget ...
Our films are about the size of a postage stamp and can deliver therapeutic actives through the oral mucosal tissue, sublingually or buccally – between the cheek and gum – or more traditionally via the ...
based inLund, SWEDEN
Camurus is committed to developing and commercializing innovative and long-acting medicines for the treatment of severe and chronic conditions, including opioid dependence, pain, cancer and endocrine disorders. New drug products are based on our ...
episil® oral liquid is a medical device for treatment of inflammatory and painful conditions in the oral cavity. The product provides fast pain relief and protection of sore and inflamed mucosal ...
based inMalvern, PENNSYLVANIA (USA)
We are a clinical stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer. We leverage our expertise in superoxide dismutase ...
based inMonmouth Junction, NEW JERSEY (USA)
MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet ...
based inCambridge, UNITED KINGDOM
GW is the global leader in developing cannabinoid-based medicines. GW has been researching cannabinoids since 1998 and has established a world leading position in the development of plant-derived cannabinoid therapeutics. GW has established a world ...
based inNew York, NEW YORK (USA)
Intrommune is a New York City-based biotechnology company dedicated to simplifying allergy immunotherapy. Intrommune’s core technology enables immunotherapeutic agents to be delivered in a specially formulated toothpaste designed to incorporate and ...
Intrommune has developed a novel drug delivery platform—oral mucosal immunotherapy (OMIT)—for the treatment of food allergies. Therapeutic agents are embedding in fully functioning toothpaste so that ...
based inLund, SWEDEN
BrainCool AB is a medtech company specializing in advanced cooling systems designed for medical emergencies and critical care applications. Their product lines, including BrainCool System, RhinoChill, and Cooral System, are designed to offer ...
The Cooral System offers a big step forward in improving the quality of life for patients by providing medical professionals an easy way to reduce the risk of oral mucositis (mouth sores). The Cooral System is a ...
based inBrighton, UNITED KINGDOM
Destiny Pharma is a clinical phase biotechnology company dedicated to the development of novel anti-infectives with a focus on infection prevention. We have two exciting late-stage clinical assets and a range of earlier research programmes. Our ...
based inOxfordshire, UNITED KINGDOM
GFC Diagnostics was formed in 2007 to promote and develop the SmokeScreen and other SafeTube products. The initial invention and development was carried out in the University of Birmingham. This work was supported by the UK's Department of Health. ...
based inGangnam-gu, SOUTH KOREA
MitoImmune Therapeutics Inc. is a drug discovery and development biotech company that harnesses the power of mitochondria and its proprietary technology targeting mitochondria as the source for developing new potential breakthrough therapeutics. Our ...
MIT-001 is expected to meet the medical need for oral mucositis for which there is no cure. It aims to be a first-in-class drug that can be used by both patients with head and neck cancer or hematological cancer ...
based inNew York City, NEW YORK (USA)
Allovate Therapeutics is a specialty biopharmaceutical company dedicated to simplifying allergy treatment by providing safe, effective, and convenient new options for allergy sufferers. Oral mucosal immunotherapy (OMIT) is a novel form of ...
Oral mucosal immunotherapy (OMIT) is a novel form of allergen-specific immunotherapy. Immunotherapy has a 100-year track record of success for respiratory allergies. OMIT improves upon this approach by delivering ...
based inAmersham, UNITED KINGDOM
THOR has over 5,000 customers in pioneering clinics and hospitals in more than 70 countries and is the only company with FDA, CE, TGA and NATO clearance, and we are also listed on GSA, and eCAT in the United States for government purchases. Since ...
based inCloster, NEW JERSEY (USA)
Chemo Mouthpiece is a safe, reliable, and easy-to-use cryotherapy device that can effectively minimize the painful effects of oral mucositis caused by ...
based inDevon, PENNSYLVANIA (USA)
At Zynerba Pharmaceuticals, our team is dedicated to developing next-generation transdermally-delivered cannabinoid therapeutics for patients affected by rare and near-rare neuropsychiatric conditions. Often, these diseases have few, if any, ...
based inHergiswil, SWITZERLAND
BioLingus is a Swiss biotech company spearheading the development of oral (sublingual) delivery of peptides and proteins for chronic diseases and immuno-therapy via our innovative formulation technology. Our company focuses on the development of ...
